Severe Nitrofurantoin-Induced Lung Toxicity

Interstitial lung disease (ILD) is a rare adverse effect of nitrofurantoin and can range from benign infiltrates to a fatal condition. Nitrofurantoin acts via inhibiting the protein synthesis in bacteria by helping reactive intermediates and is known to produce primary lung parenchymal injury through an oxidant mechanism. Stopping the drug leads to complete recovery of symptoms. In this report, we present a case of nitrofurantoin-induced ILD with the recovery of symptoms and disease process after stopping the drug.

show abstract

Nitrofurantoin-induced interstitial pneumonitis: albeit rare, should not be missed

Syed

Bachuwa

Upadhaya

et al. 2016

BMJ Case Reports

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Severe Nitrofurantoin-Induced Lung Toxicity

Cited by 1 publication

References 9 publications

Nitrofurantoin-induced interstitial pneumonitis: albeit rare, should not be missed

Nitrofurantoin-induced interstitial pneumonitis: albeit rare, should not be missed

Contact Info

Product

Resources

About